NEW YORK (GenomeWeb) – The Rady Children's Institute for Genomic Medicine (RCIGM) and Alexion Pharmaceuticals announced today that they have partnered to develop the company's SmartPanel precision medicine platform for use in newborns with rare genetic disorders.